New Risk • May 20
New minor risk - Profit margin trend The company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 5.4% Last year net profit margin: 11% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risks Dividend is not well covered by earnings and cash flows. Payout ratio: 95% Cash payout ratio: 142% Earnings have declined by 6.3% per year over the past 5 years. Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (5.4% net profit margin). Upcoming Dividend • May 04
Upcoming dividend of ر.س0.08 per share Eligible shareholders must have bought the stock before 11 May 2026. Payment date: 24 May 2026. Payout ratio is on the higher end at 95%, and the cash payout ratio is above 100%. Trailing yield: 2.8%. Lower than top quartile of Saudi dividend payers (5.9%). Higher than average of industry peers (2.5%). Announcement • Apr 14
Canadian General Medical Center Complex Company, Annual General Meeting, May 04, 2026 Canadian General Medical Center Complex Company, Annual General Meeting, May 04, 2026, at 19:00 Arab Standard Time. Location: dammam Saudi Arabia Declared Dividend • Mar 04
Dividend of ر.س0.80 announced Shareholders will receive a dividend of ر.س0.80. Ex-date: 11th May 2026 Payment date: 24th May 2026 Dividend yield will be 15%, which is higher than the industry average of 1.5%. Sustainability & Growth Dividend is covered by earnings (47% earnings payout ratio) but not covered by cash flows (169% cash payout ratio). The dividend has decreased over the past 46 years, indicating a lack of growth and stability in payments. The company's earnings per share (EPS) would need to decline by 47% to shift the payout ratio to a potentially unsustainable range, which is more than the 45% EPS decline seen over the last 5 years. New Risk • Dec 21
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Saudi stocks, typically moving 7.0% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (7.0% average weekly change). Earnings have declined by 3.0% per year over the past 5 years. High level of non-cash earnings (21% accrual ratio). Announcement • Dec 18
Canadian General Medical Center Complex Company Announces Board Appointments Canadian General Medical Center Complex Company at the Ordinary General Assembly Meeting held on December 16, 2025 approved the election of the Board of Directors from among the candidates for the upcoming term, which shall commence on 28 December 2025 for a period of four years ending on 27 December 2029. The following members were elected: Mr. Khalid Mohammed Al-Ammar Al-Dossary, Mr. Abdullatif Khalifah Abdullatif Almulhem, Mr. Fahad Abdulrahman Al Misehal, Mr. Mohammed Mueed Yahia ALQahtani, Mr. Hamad Muhammad AlAli Al Dhewalia. New Risk • Oct 15
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Saudi stocks, typically moving 5.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 4.2% per year over the past 5 years. High level of non-cash earnings (33% accrual ratio). Minor Risk Share price has been volatile over the past 3 months (5.7% average weekly change). Upcoming Dividend • Oct 06
Upcoming dividend of ر.س0.05 per share Eligible shareholders must have bought the stock before 13 October 2025. Payment date: 26 October 2025. Payout ratio is a comfortable 25% but the company is not cash flow positive. Trailing yield: 1.2%. Lower than top quartile of Saudi dividend payers (5.1%). Lower than average of industry peers (1.7%). Valuation Update With 7 Day Price Move • Oct 06
Investor sentiment improves as stock rises 20% After last week's 20% share price gain to ر.س8.40, the stock trades at a trailing P/E ratio of 42.6x. Average trailing P/E is 27x in the Healthcare industry in Saudi Arabia. Total returns to shareholders of 77% over the past three years. New Risk • Sep 13
New major risk - Revenue and earnings growth Earnings have declined by 4.2% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 4.2% per year over the past 5 years. High level of non-cash earnings (33% accrual ratio). New Risk • Aug 28
New major risk - Financial data availability The company's latest financial reports are more than a year old. Last reported fiscal period ended June 2024. This is considered a major risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. In the worst case scenario, it may be facing other major going concern issues jeopardizing its viability as a listed company. Currently, the following risks have been identified for the company: Major Risk Latest financial reports are more than 1 year old (reported June 2024 fiscal period end). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (10% net profit margin). Announcement • May 14
Canadian General Medical Center Complex Company, Annual General Meeting, Jun 15, 2025 Canadian General Medical Center Complex Company, Annual General Meeting, Jun 15, 2025, at 19:00 Arab Standard Time. Location: dammam Saudi Arabia Valuation Update With 7 Day Price Move • May 12
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ر.س7.09, the stock trades at a trailing P/E ratio of 49.3x. Average trailing P/E is 25x in the Healthcare industry in Saudi Arabia. Total returns to shareholders of 14% over the past three years. Upcoming Dividend • May 05
Upcoming dividend of ر.س0.05 per share Eligible shareholders must have bought the stock before 12 May 2025. Payment date: 25 May 2025. Trailing yield: 3.1%. Lower than top quartile of Saudi dividend payers (5.3%). Higher than average of industry peers (1.7%). Declared Dividend • Mar 20
Dividend of ر.س0.05 announced Shareholders will receive a dividend of ر.س0.05. Ex-date: 12th May 2025 Payment date: 25th May 2025 Dividend yield will be 0.7%, which is lower than the industry average of 1.5%. Sustainability & Growth Dividend is covered by earnings (63% earnings payout ratio) but not covered by cash flows (221% cash payout ratio). The dividend has decreased over the past 46 years, indicating a lack of growth and stability in payments. The company's earnings per share (EPS) would need to decline by 30% to shift the payout ratio to a potentially unsustainable range, which is less than the 49% EPS decline seen over the last 5 years. Announcement • Mar 19
Canadian General Medical Center Complex Company announces Annual dividend, payable on May 25, 2025 Canadian General Medical Center Complex Company announced Annual dividend of SAR 0.0500 per share payable on May 25, 2025, ex-date on May 12, 2025 and record date on May 13, 2025. New Risk • Mar 15
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 1.3% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported June 2024 fiscal period end). Dividend is not well covered by cash flows (221% cash payout ratio). Profit margins are more than 30% lower than last year (10% net profit margin). Valuation Update With 7 Day Price Move • Nov 18
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to ر.س7.32, the stock trades at a trailing P/E ratio of 50.9x. Average trailing P/E is 29x in the Healthcare industry in Saudi Arabia. Total returns to shareholders of 15% over the past three years. New Risk • Nov 17
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Saudi stocks, typically moving 6.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 1.3% per year over the past 5 years. Minor Risks Dividend is not well covered by cash flows (221% cash payout ratio). Share price has been volatile over the past 3 months (6.2% average weekly change). Profit margins are more than 30% lower than last year (10% net profit margin). Valuation Update With 7 Day Price Move • Oct 17
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ر.س6.30, the stock trades at a trailing P/E ratio of 43.8x. Average trailing P/E is 33x in the Healthcare industry in Saudi Arabia. Total loss to shareholders of 14% over the past three years. New Risk • Sep 05
New major risk - Revenue and earnings growth Earnings have declined by 1.3% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Dividend is not well covered by earnings and cash flows. Payout ratio: 136% Cash payout ratio: 221% Earnings have declined by 1.3% per year over the past 5 years. Minor Risk Profit margins are more than 30% lower than last year (10% net profit margin). Announcement • Jun 01
Canadian General Medical Center Complex Company, Annual General Meeting, Jun 24, 2024 Canadian General Medical Center Complex Company, Annual General Meeting, Jun 24, 2024, at 18:30 Arab Standard Time. Location: dammam Saudi Arabia Upcoming Dividend • Apr 29
Upcoming dividend of ر.س0.09 per share Eligible shareholders must have bought the stock before 06 May 2024. Payment date: 21 May 2024. Trailing yield: 2.2%. Lower than top quartile of Saudi dividend payers (4.7%). Higher than average of industry peers (1.3%). New Risk • Mar 07
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Dividend is not well covered by cash flows (101% cash payout ratio). Share price has been volatile over the past 3 months (5.6% average weekly change). Announcement • Jan 29
Canadian Medical Center Company Announces CEO Changes Canadian Medical Center Company revealed that Hasan Joudah has resigned from his position as the CEO due to personal circumstances, according to a bourse filing. Joudah, who will remain as a board member, submitted his resignation on 28 January 2024. Mohammed Yanouri succeeded Joudah as the company's new CEO, bringing more than 25 years of experience in the field of business and medical projects both locally and internationally. Yanouri is a British national who held key positions, including the Planning Director at Saad Specialist Hospital, CEO of Medical Rescue, and General Manager of International SOS Al-Rushaid Company. The new official also assumed administrative roles with the National Health Service (NHS) and American Express Europe (Amex). Furthermore, he obtains a master's degree in Healthcare Management from the UK. It is worth mentioning that Jouda was appointed as the CEO of Canadian Medical Center in January 2023 after Waddah Muhammad Al Ammar left the position. Valuation Update With 7 Day Price Move • Jan 11
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ر.س7.00, the stock trades at a trailing P/E ratio of 34.3x. Average trailing P/E is 36x in the Healthcare industry in Saudi Arabia. Total returns to shareholders of 49% over the past year. Announcement • Aug 25
Saudi Advanced Industries Company (SASE:2120) acquired 49.9% stake in Canadian General Medical Center Complex Company (SASE:9518) from Khalid Mohamed Farhan Al-Dossary for SAR 24.9 million. Saudi Advanced Industries Company (SASE:2120) acquired 49.9% stake in Canadian General Medical Center Complex Company (SASE:9518) from Khalid Mohamed Farhan Al-Dossary for SAR 24.9 million on August 24, 2023. Under the terms of agreement, Saudi Advanced Industries is purchasing of shares in the Canadian General Medical Center Complex Company of 3,846,000 shares valued at SAR 24,999,000. This deal is part of a company's evolving strategy to expand its investments and target the most vibrant sectors, investment attraction and alignment with Saudi Arabia's 2030 orientations and vision. There are no preferential or special conditions. Saudi Advanced Industries Company expects to show the financial impact of the deal in the third quarter of this year.Saudi Advanced Industries Company (SASE:2120) completed the acquisition of 49.9% stake in Canadian General Medical Center Complex Company (SASE:9518) from Khalid Mohamed Farhan Al-Dossary on August 24, 2023. Valuation Update With 7 Day Price Move • Jul 10
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to ر.س6.60, the stock trades at a trailing P/E ratio of 32.5x. Average trailing P/E is 42x in the Healthcare industry in Saudi Arabia. Total returns to shareholders of 37% over the past year. Buying Opportunity • Jun 20
Now 68% undervalued after recent price drop Over the last 90 days, the stock is down 87%. The fair value is estimated to be ر.س17.19, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 15% over the last year. Earnings per share has grown by 11%. New Risk • Jun 15
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Saudi stocks, typically moving 5.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Dividend is not well covered by earnings and cash flows. Payout ratio: 98% Cash payout ratio: 94% Minor Risk Share price has been volatile over the past 3 months (5.4% average weekly change). Valuation Update With 7 Day Price Move • Jun 08
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ر.س53.30, the stock trades at a trailing P/E ratio of 26.2x. Average trailing P/E is 39x in the Healthcare industry in Saudi Arabia. Total loss to shareholders of 6.3% over the past year. Upcoming Dividend • Mar 26
Upcoming dividend of ر.س0.50 per share at 2.3% yield Eligible shareholders must have bought the stock before 02 April 2023. Payment date: 13 April 2023. The company is paying out more than 100% of its earnings and cash flow. Trailing yield: 2.3%. Lower than top quartile of Saudi dividend payers (4.7%). Higher than average of industry peers (1.5%). Announcement • Jan 12
Canadian Medical Center Co. Announces Resignation of a Mr. Waddah Muhammed Al-Ammar as Board Member Canadian General Medical Center Complex Company announced the Resignation of its Board Member Mr. Waddah Muhammed Al-Ammar from his position as Board member (Executive) on January 10, 2023 for personal reasons. A replacement board member will be appointed at a later time. Announcement • Jan 11
Canadian General Medical Center Complex Company Announces CEO Changes Canadian General Medical Center Complex Company announced the approval of its Board of Directors on January 10, 2023 the resignation of Mr. Waddah Muhammad Al-Ammar from his position as Chief Executive Officer due to his Personal reasons, as it will take effect as of January 10, 2023. The company furthermore announced the appointment of Mr. Hassan Jouda as Chief Executive Officer with effect from January 11, 2023. Mr. Hassan Jouda holds a master's degree in Business Administration from Almeida University in Idaho, USA, in 2003. He holds a Bachelor's degree in English from the University of Riyadh in the city of Riyadh in 1978.Mr. Hassan Joudeh has held several leadership positions in a number of companies and has been included in several positions within the company, including Chief Operating Officer. Valuation Update With 7 Day Price Move • Dec 12
Investor sentiment deteriorated over the past week After last week's 16% share price decline to ر.س41.90, the stock trades at a trailing P/E ratio of 18.9x. Average trailing P/E is 33x in the Healthcare industry in Saudi Arabia. Total loss to shareholders of 40% over the past year. Announcement • Dec 07
Canadian Medical Center Co. Announces Resignation of Mousaed Mohammed AlMunaifi From His Position as Board Member (Independent) Canadian Medical Center Co. announced the Resignation of its Board Member Mr. Mousaed Mohammed AlMunaifi from his position as Board member (Independent) on December 6, 2022 for personal reasons. A replacement board member will be appointed at a later time. Board Change • Nov 16
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 7 non-independent directors. was the last director to join the board, commencing their role in . The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. Upcoming Dividend • Sep 05
Upcoming dividend of ر.س1.50 per share Eligible shareholders must have bought the stock before 12 September 2022. Payment date: 22 September 2022. The company is paying out more than 100% of its earnings and cash flow. Trailing yield: 5.9%. Within top quartile of Saudi dividend payers (4.4%). Higher than average of industry peers (1.6%). Reported Earnings • Sep 02
First half 2022 earnings released: EPS: ر.س1.03 (vs ر.س0.65 in 1H 2021) First half 2022 results: EPS: ر.س1.03 (up from ر.س0.65 in 1H 2021). Revenue: ر.س38.9m (up 29% from 1H 2021). Net income: ر.س7.94m (up 60% from 1H 2021). Profit margin: 20% (up from 16% in 1H 2021). The increase in margin was driven by higher revenue. Announcement • Aug 30
Canadian Medical Center Co. Announces the Distribution of Cash Dividend for the First Half of 2022 The board of directors of Canadian General Medical Center Complex Company on 29 August 2022 resolved to distribute cash dividends of SAR 1.5 per share for the first half of 2022. The Total amount distributed: SAR 11,550,000; Number of Shares Eligible for Dividends: 7,700,000. The eligibility of dividends shall be for the shareholders who own shares on closing of 11 September 2022. Dividend to the Share Par Value: 15%. Board Change • Apr 27
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 7 non-independent directors. was the last director to join the board, commencing their role in . The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Mar 29
Full year 2021 earnings released: EPS: ر.س1.83 (vs ر.س41.96 in FY 2020) Full year 2021 results: EPS: ر.س1.83 (down from ر.س41.96 in FY 2020). Revenue: ر.س70.6m (up 10.0% from FY 2020). Net income: ر.س14.1m (down 13% from FY 2020). Profit margin: 20% (down from 25% in FY 2020). The decrease in margin was driven by higher expenses. 
